title: What is the best therapy for toxicity in the setting of methotrexate-associated acute kidney injury: high-flux hemodialysis or carboxypeptidase G2?
authors.affiliation: Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Neelja
authors.initials: N
authors.lastname: Kumar
authors.forename: Anushree C
authors.initials: AC
authors.lastname: Shirali
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000453:epidemiology / Q000628:therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007262:Infusions, Intravenous; D007668:Kidney / Q000187:drug effects; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D011379:Prognosis; D006435:Renal Dialysis / Q000379:methods*; D011623:gamma-Glutamyl Hydrolase / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D011623:gamma-Glutamyl Hydrolase; D008727:Methotrexate